#Cuba #CienciaCubana

May

22

2024

Cuba will extend the use of Biomodulin T to primary health care

Primary health care will include the use of Biomodulin T, based on the positive results of this Cuban medicine in the treatment of infections in children and older adults.

Miguel Díaz-Canel, First Secretary of the Central Committee of the Communist Party of Cuba and President of the Republic, indicated in a meeting with health experts to expedite the process so that the drug can be prescribed in Cuban communities, the Presidency reported on the website of he.

Apr

06

2023

Cuban science present at the most important global event on Alzheimer's and Parkinson's

The clinical results of the neuroprotective drug NeuralCIM® (trade name of the NeuroEPO molecule) in neurodegenerative diseases, in Cuba; were exposed in recent days to the international scientific community, in the most important event on the subject that takes place in the world: the International Conference on Alzheimer's and Parkinson's disease (ADPD 2023), which was held in Sweden from March 28 to March 1. of April.